US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Boston Scientific (NY:BSX)

42.19 -0.21 (-0.50%)
Official Closing Price Updated: 4:10 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
News headline image
2 Cash-Producing Stocks Worth Investigating and 1 That Underwhelm
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
2 Oversold Stocks Primed to Rebound and 1 We Find Risky
The past year hasn’t been kind to the stocks featured in this article. Each has tumbled to its lowest point in 12 months, leaving investors to decide whether... 
Via StockStory
News headline image
2 Profitable Stocks to Research Further and 1 We Avoid
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
Via StockStory
News headline image
2 Value Stocks with Exciting Potential and 1 We Avoid
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built the... 
Via StockStory
Boston Scientific (NYSE:BSX) Stands Out as a Quality Investment ↗
Via Chartmill
Boston Scientific (NYSE:BSX) Screens as a Decent Value with Strong Fundamentals ↗
Via Chartmill
News headline image
Unpacking Q2 Earnings: Boston Scientific (NYSE:BSX) In The Context Of Other Medical Devices & Supplies - Diversified Stocks
Looking back on medical devices & supplies - diversified stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Boston Scientifi... 
Via StockStory
News headline image
1 of Wall Street’s Favorite Stocks with Promising Prospects and 2 Facing Challenges
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
News headline image
2 Healthcare Stocks with Competitive Advantages and 1 We Question
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali... 
Via StockStory
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
These S&P500 stocks are moving in today's pre-market session ↗
Via Chartmill
Thursday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
2 Reasons to Watch BSX and 1 to Stay Cautious
Boston Scientific has gotten torched over the last six months - since March 2026, its stock price has dropped 36.9% to $48.10 per share. This was partly due ... 
Via StockStory
News headline image
1 Stock Under $50 to Target This Week and 2 We Ignore
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha... 
Via StockStory
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
News headline image
3 Healthcare Stocks with Promising Prospects
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva... 
Via StockStory
News headline image
Stock Market Today, Aug. 26: Boston Scientific Shares Fall 5% on Cybersecurity Incident and Product Recall ↗
On Aug. 26, 2026, a cyberattack halted order processing and shipping at the medical device maker, leaving investors uncertain about the speed of recovery and near-term shipment delays. 
Via The Motley Fool
Topics Stocks
Explore the S&P500 index on Wednesday and find out which stocks are the most active in today's session. ↗
Via Chartmill
News headline image
Why Boston Scientific Stock Crashed Today ↗
The medical device specialist was the victim of a cyberattack. 
Via The Motley Fool
Topics Artificial Intelligence Data Breach
What's going on in today's session: S&P500 movers ↗
Via Chartmill
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
Top S&P500 movers in Wednesday's pre-market session ↗
Via Chartmill
News headline image
If You Invested $1000 In Boston Scientific Stock 15 Years Ago, You Would Have This Much Today ↗
Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.54% on an annualized basis producing an average annual return of 15.01%. Currently, Boston Scientific has a market... 
Via Benzinga
Get insights into the top movers in the S&P500 index of Friday's pre-market session. ↗
Via Chartmill
News headline image
Boston Scientific Director Habiger Buys $100k of Shares Amid 54% Decline. What Does This Mean for BSX in 2026? ↗
Habiger's $100,000 purchase expanded his direct holdings by 14%, signaling confidence despite the stock's recent weakness. The acquisition came as shares traded near their lowest levels in over a... 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Boston Scientific CEO Mahoney Buys More Than 200k Shares for $10 Million. What Does This Mean for Investors in 2026? ↗
Mahoney expanded his equity stake by 13% following a -54% one-year stock decline. His combined holdings now total ~1.6 million shares valued at $78.08 million. 
Via The Motley Fool
Topics Regulatory Compliance Retirement
News headline image
Boston Scientific (BSX) Q2 2026 Earnings Call Transcript ↗
WATCHMAN and Electrophysiology headwinds force guidance cut despite solid organic growth. 
Via The Motley Fool
Topics Earnings
Stay updated with the S&P500 stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Boston Scientific’s Q2 Earnings Call: Our Top 5 Analyst Questions
Boston Scientific's second quarter was shaped by healthy growth in its Interventional Cardiology, Endoscopy, and Neuromodulation businesses, which counterbal... 
Via StockStory
Topics Earnings
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >